Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography

被引:38
作者
Foy, CA [1 ]
Rice, GI [1 ]
OsseiGerning, N [1 ]
Mansfield, MW [1 ]
Grant, PJ [1 ]
机构
[1] UNIV LEEDS,GEN INFIRM,UNIT MOL VASC MED,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
关键词
D O I
10.1007/s004390050527
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The angiotensin converting enzyme (ACE) gene is implicated as a risk factor for coronary artery disease and myocardial infarction (MI). An insertion/deletion (I/D) polymorphism is believed to be in linkage disequilibrium with a functional site elsewhere. Ten polymorphisms have recently been identified in the ACE gene. We screened patients undergoing coronary angiography (n = 258) for six of these polymorphisms (T-5491C, T-93C, A-240T, T1237C. D/I and 4656(CT)(2/3)), and identified a further two rare polymorphisms. ACE levels were associated with genotype for all polymorphisms analysed individually by one way ANOVA (P < 0.0005). The polymorphisms occurring in the 5' region were in negative linkage disequilibrium with the exonic and 3' region polymorphisms. The A-240T polymorphism had the greatest association with ACE levels (R-2 = 14%); none of the others were significantly associated with levels when adjustment was made for A-240T. None of the polymorphisms were associated with the extent of coronary atheroma. Two of the promoter polymorphisms (A-240T and T-93C) were weakly related to the occurrence of MI (P = 0.03 and P = 0.05, respectively, by chi(2) analysis). The TT genotype of A-240T appeared to be protective against MI with an odds ratio of 0.31 (95% confidence interval, 0.12, 0.83). These findings indicate that polymorphisms in the ACE gene promoter region may have a stronger association with disease than the I/D polymorphism.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 24 条
[1]   ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE AND THE DEVELOPMENT OF MYOCARDIAL-INFARCTION [J].
AMBROSE, JA ;
TANNENBAUM, MA ;
ALEXOPOULOS, D ;
HJEMDAHLMONSEN, CE ;
LEAVY, J ;
WEISS, M ;
BORRICO, S ;
GORLIN, R ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (01) :56-62
[2]  
Barrett JH, 1996, GENET EPIDEMIOL, V13, P615, DOI 10.1002/(SICI)1098-2272(1996)13:6<615::AID-GEPI7>3.0.CO
[3]  
2-Z
[4]  
BAUMANN RE, 1994, HUM GENET, V94, P165
[5]  
BOHN M, 1993, CLIN GENET, V44, P292
[6]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[7]  
EVANS AE, 1994, Q J MED, V87, P211
[8]  
HUBERT C, 1991, J BIOL CHEM, V266, P15377
[9]   A PROSPECTIVE EVALUATION OF AN ANGIOTENSIN-CONVERTING-ENZYME GENE POLYMORPHISM AND THE RISK OF ISCHEMIC-HEART-DISEASE [J].
LINDPAINTNER, K ;
PFEFFER, MA ;
KREUTZ, R ;
STAMPFER, MJ ;
GRODSTEIN, F ;
LAMOTTE, F ;
BURING, J ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :706-711
[10]  
MANSFIELD M, 1994, THROMB HAEMOSTASIS, V71, P1